Navigation Links
XLHealth Appoints New Vice President of Contracting and Provider Relations
Date:7/1/2009

BALTIMORE, July 1 /PRNewswire/ -- XLHealth, owner of one of the nation's largest Medicare chronic condition special needs plans and a leader in improving the quality of care for seniors with chronic illness, announced today that it has appointed Karl Broussard to serve as its vice president of contracting and provider relations. In his new position, Broussard is responsible for the establishment, strategic planning, and management for the company's Medicare Advantage chronic condition Special Needs Plan, Care Improvement Plus. He will also oversee the development and management of relationships with key medical groups, hospitals, and physicians contracted with Care Improvement Plus in the six states in which it operates.

Broussard has more than 25 years' experience in the healthcare, business, and finance industries. Prior to joining XLHealth, Broussard served nine years in various executive roles at Coventry Health Care, most recently as vice president of network development with the company's Vista health plan. In that role, he managed all aspects of Vista's Health Plan network operations and network development as well as Coventry owned non Health Plan products and entities. This oversight included HMO, PPO, Individual, Medicare, Medicaid, Healthy Kids, and Workers' Compensation products for the state of Florida. Broussard's experience also includes positions with Independent Physician Strategies, MedPartners, Inc., FamilyPlus Health Plans of Georgia, Inc., and First Health, Inc.

"Karl brings a wealth of experience in the network development sector to his position," said Lee Spruiell, Senior Vice President of Field Operations for XLHealth. "We are excited to bring him on board to help us continue our commitment to bringing high-quality services to the providers we work with."

Broussard received a Bachelor's of Science degree in accounting from Nicholls State University in Thibodaux, Louisiana, a Masters of Business Administration from the University of Southern Mississippi in Hattiesburg, MS and a Masters of Science in Health Care Policy and Administration from Mercer University in Atlanta, Georgia.

About XLHealth

XLHealth (http://www.xlhealth.com), a Baltimore-based organization focused on improving the healthcare of chronically ill seniors, is the owner and operator of Care Improvement Plus, one of the nation's largest chronic condition special needs plans. Care Improvement Plus provides a complete Medicare Advantage Part D health plan including disease management services to Medicare beneficiaries living with heart failure, diabetes, chronic obstructive pulmonary disease and/or end-stage renal disease. XLHealth has earned Full Accreditation from the National Committee for Quality Assurance (NCQA) under its standards for patient and practitioner-oriented accreditation of disease management programs.


'/>"/>
SOURCE XLHealth
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. XLHealth Statement on Social Security and Medicare Trustees Report
2. XLHealth Statement on Senate Finance Committee Roundtable on Healthcare Reform
3. XLHealth Appoints New CFO, Adds Two Additional Executives
4. XLHealth Corporation Announces Executive Changes
5. Wisconsin Tobacco Tax Increase Is Positive Step for Health, but Budget Disappoints by Cutting Funding for Tobacco Prevention Programs
6. Verathon Inc. Appoints Kendall Stever as Chief Financial Officer
7. Tyco Electronics Appoints Cuong Do as Senior Vice President, Corporate Strategy & Business Development
8. Symmetry Medical Appoints Chairman and Two Directors
9. GBS/CIDP Foundation International Appoints Patricia A. Bryant as Executive Director
10. DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy
11. Cinergy Health Appoints Dr. Erika Schwartz as Medical Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2017)... Angeles, California (PRWEB) , ... May 26, 2017 , ... ... senior citizens who visit a doctor for colds or respiratory issues that are not ... that excessive time pressure on doctors may be largely responsible for the problem both ...
(Date:5/27/2017)... ... , ... Most us are familiar with the sound of occasional popping joints ... Initiative shows that certain people who experience consistent joint popping, grating and grinding ... the opportunity to treat patients before the problem becomes pronounced, potentially hedging off more ...
(Date:5/26/2017)... ... May 26, 2017 , ... The ... educational seminar to focus on current legislative activity and the latest regulatory concerns ... 1 p.m. Sunday, Sept. 10, and will continue through Monday, Sept. 11, at ...
(Date:5/26/2017)... ... 2017 , ... Boar’s Head Brand®, one of the nation’s ... entertaining that are sure to satisfy your guests’ flavor cravings, while adding delicious ... featured in these refreshingly balanced recipes are packed with flavor, creating the perfect ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Yisrayl Hawkins, ... new publication this week that is focusing on the Peace Agreements being discussed by ... Middle East sprint in a race to try to speed up peace talks in ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... May 22, 2017  As the specialty pharmacy ... continue to make the revolutionary shift from volume-based ... for ensuring positive patient outcomes and shaping the ... shifting focus away from clinical trials and toward ... long-term specialty drug therapy utilization in precise patient ...
(Date:5/18/2017)... 2017  Bayer announced today that the latest research ... at the 53 rd Annual Meeting of the ... 2-6 in Chicago . ... colorectal, liver and thyroid cancers, as well as lymphomas, ... CHRONOS-1 trial of copanlisib in patients with relapsed or ...
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
Breaking Medicine Technology: